Clinical outcome of pancreatic cancer patients with diabetes mellitus: is diabetes a poor prognostic factor? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Diabetes mellitus and its related factors such as hyperinsulinemia have been linked to various cancer risks and outcomes. Previous research has offered inconsistent results in terms of relationship between diabetes and pancreatic cancers. Establishing clear association between these two entities may guide us in improving clinical outcomes of pancreatic cancer patients. Two abstracts that examined the association between diabetes mellitus and pancreatic cancer are updated in this paper. Herein, the authors report updated information from the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting in association between pancreatic cancer and diabetes mellitus. The present paper illustrates insufficient knowledge base to draw a conclusion in this topic. However, validation and understanding of the association could have significant clinical implications with respect to cancer prevention, early detection, and treatment. As such, further investigations are warranted to explore the link diabetes and pancreatic cancers.
Kang
Soonmo Peter
SP
Department of Medicine, University of Chicago, Chicago, IL, USA.
Saif
Muhammad Wasif
MW
D002277:Carcinoma / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D002641:Chicago; D003226:Congresses as Topic; D048909:Diabetes Complications / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D008495:Medical Oncology / Q000379:methods / Q000639:trends; D010190:Pancreatic Neoplasms / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D011379:Prognosis; D012955:Societies, Medical / Q000458:organization & administration; D016896:Treatment Outcome; D014481:United States